Chair: Jiten Vora (GBR)
| 13:00 – 13:10 | Targeting underlying pathophysiology in obesity and metabolic dysfunction | Jiten Vora (GBR) |
| 13:10 – 13:25 | Obesity as a disease: integrating pathways for glucose and weight regulation | Alice Cheng (CAN) |
| 13:25 – 13:30 | Audience Q&A | Alice Cheng (CAN) |
| 13:30 – 13:45 | Incretin pathophysiology as a driver for CKD | Hiddo J.L. Heerspink (NLD) |
| 13:45 – 13:50 | Audience Q&A | Hiddo J.L. Heerspink (NLD) |
| 13:50 – 14:05 | Understanding MASH: from pathophysiology to therapeutic approaches | Philip Newsome (GBR) |
| 14:05 – 14:10 | Audience Q&A | Philip Newsome (GBR) |
| 14:10 – 14:30 | Bringing the evidence together: from pathways to clinical outcomes (Panel discussion) | All faculty |
- Monday, 28 September 2026
- 13:00 - 14:30 CEST
- Vienna Hall